Back
ACS, Actividades de Construcción y Servicios SA Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Buy
71
ACSAF
ACS, Actividades de Construcción y Servicios SA
Last Price:
$92.32
Seasonality Move:
-0.31%
Buy
54
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$61.19
Seasonality Move:
5.52%
Buy
71
ACS, Actividades de Construcción y Servicios SA (ACSAF)
is a Buy
Is ACS, Actividades de Construcción y Servicios SA a Buy, Sell or Hold?
-
The current ACS, Actividades de Construcción y Servicios SA [ACSAF] share price is $92.32. The Score for ACSAF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
ACSAF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACSAF Stock Price Chart
What is ACS, Actividades de Construcción y Servicios SA's stock price today?
-
The ACS, Actividades de Construcción y Servicios SA share price today is $92.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACSAF is experiencing slight buying pressure.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $61.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
ACSAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.02 | Buy |
| Relative Strength Index (14 RSI): | 69.95 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.29 - 93.89) | Buy |
| Bollinger Bands (100): | (73.37 - 87.53) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 73.39 | Buy |
| Chaikin Money Flow: | 7836963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.19 - 56.01) | Buy |
| Bollinger Bands (100): | (52.65 - 57.43) | Buy |
ACSAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.32 | Sell |
| 20-day SMA: | 90.82 | Buy |
| 50-day SMA: | 85.29 | Buy |
| 200-day SMA: | 71.57 | Buy |
| 8-day EMA: | 92.21 | Buy |
| 20-day EMA: | 90.78 | Buy |
| 50-day EMA: | 86.51 | Buy |
| 200-day EMA: | 72.97 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.6 | Buy |
| 20-day SMA: | 54.21 | Buy |
| 50-day SMA: | 53.61 | Buy |
| 200-day SMA: | 57.94 | Buy |
| 8-day EMA: | 54.44 | Buy |
| 20-day EMA: | 53.99 | Buy |
| 50-day EMA: | 54.1 | Buy |
| 200-day EMA: | 58.28 | Buy |
ACS, Actividades de Construcción y Servicios SA Earnings Growth & ACSAF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.
ACS, Actividades de Construcción y Servicios SA Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||